Current options in prosthetic vascular graft infection

Henke, Peter K.; Bergamini, Thomas M.; Rose, Scott M.; Richardson, J. David
January 1998
American Surgeon;Jan1998, Vol. 64 Issue 1, p39
Academic Journal
Evaluates outcome of treatment on patients with prosthetic vascular graft infections. Patients and methods utilized on the study; Alternative strategies that have emerged to circumvent vascular graft infection; Recovered organisms in patients used on the study.


Related Articles

  • Vascular and Cardiac Surgery I.  // European Surgical Research;1999 Supplement 1, Vol. 31, p136 

    Presents a summary of studies on Vascular and Cardiac Surgery I from the journal European Surgical Research. Effect of prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts; Result of balloon angioplasty and stenting in mechanically reconstructed arteries;...

  • Nocardia Infection in Heart-Lung Transplant Recipients at Alfred Hospital, Melbourne, Australia... Roberts, S. A.; Franklin, J. C.; Spelman, D. // Clinical Infectious Diseases;10/1/2000, Vol. 31 Issue 4, p968 

    Reports on Nocardia infections or nocardiosis in patients undergoing lung-heart transplantations at Alfred Hospital in Melbourne, Victoria. Factors that increase the risk of Nocardia infection in the group; Frequency of occurrence on infection; Susceptibility of all isolates to...

  • Histoplasmosis in Solid Organ Transplant Recipients. Hage, Chadi; Kleiman, Martin B.; Wheat, L. Joseph // Clinical Infectious Diseases;1/1/2010, Vol. 50 Issue 1, p122 

    A letter to the editor is presented in response to the article "Histoplasmosis in Solid Organ Transplant Recipients," by J. Cuellar-Rodriguez and colleagues.

  • Reply to Hage et al. Cuellar-Rodriguez, J.; Avery, R. K.; Lard, M.; Budev, M.; Gordon, S. M.; Shrestha, N. K.; van Duin, D.; Mawhorter, S. D. // Clinical Infectious Diseases;1/1/2010, Vol. 50 Issue 1, p123 

    A response by J. Cuellar-Rodriguez and colleagues to a letter to the editor about their article "Histoplasmosis in Solid Organ Transplant Recipients" is presented.

  • Visceral Leishmaniasis (Kala-azar) in Solid Organ Transplantation: Report of Five Cases and Review. Hernaacutendez-Peacuterez, J.; Yebra-Bango, M.; Jimeacutenez-Martinez, E.; Sanz-Moreno, C.; Cuervas-Mons, V.; Alonso Pulpón, L.; Ramos-Martínez, A.; Fernaacutendez-Fernaacutendez, J. // Clinical Infectious Diseases;10/1/1999, Vol. 29 Issue 4, p918 

    Presents information on several case studies of visceral leishmaniasis in recipients of solid organ grafts. Background of the illness; Clinical history of the patients; Treatment.

  • Preemptive Therapy Versus Universal Prophylaxis with Ganciclovir for Cytomegalovirus in Solid Organ Transplant Recipients. Singh, Nina // Clinical Infectious Diseases;3/1/2001, Vol. 32 Issue 5, p742 

    Compares the effectiveness of preemptive therapy and universal prophylaxis with ganciclovir for treating cytomegalovirus in solid organ transplant recipients. Availability of preemptive therapy tools; Adverse effects of prophylaxis; Cost-effectiveness of the approaches.

  • Human Herpesviruses 6 and 7 in Solid Organ Transplant Recipients. Snydman, David R.; Emery, Vincent C. // Clinical Infectious Diseases;5/1/2001, Vol. 32 Issue 9, p1357 

    Focuses on a study which discussed the impact of human herpesviruses 6 and 7 (HHV-6 and HHV-7) on solid organ transplant patients. Background information on the viruses; Details on the antiviral chemotherapy for HHV-6 and HHV-7; Explanations on monitoring for HHV-6 and HHV-7 after organ...

  • Management of Cytomegalovirus Infection and Disease after Solid-Organ Transplantation. van der Bij, Wire; Speich, Rudolf // Clinical Infectious Diseases;7/1/2001 Supplement 1, Vol. 33, pS32 

    Discusses the considerable progress that has been made in elucidating risk factors for cytomegalovirus (CMV) infection in organ transplantation patients. Pathophysiology of CMV infection; Diagnosis; Prevention; Treatment.

  • Epidemiology and Management of Infections after Lung Transplantation. Speich, Rudolf; van der Bij, Wire // Clinical Infectious Diseases;7/1/2001 Supplement 1, Vol. 33, pS58 

    Discusses the epidemiology and treatment of infectious complications after lung transplantation. Pathogens which typically causes infections after lung transplantation; Microbiologic surveillance of the lung donor and recipients; Double-lung transplantation in patients with lung cystic fibrosis.

  • Coccidioidomycosis in Solid Organ Transplantation. Blair, Janis E.; Logan, Joy L. // Clinical Infectious Diseases;11/1/2001, Vol. 33 Issue 9, p1536 

    Provides information on coccidioidomycosis, an endemic fungal infection related to solid organ transplantation. Demographic characteristics of patients with coccidioidomycosis; Incidence of coccidioidomycosis after transplantation; Risk factors for coccidioidomycosis; Clinical manifestation of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics